![Melissa Epperly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Melissa Epperly
Directeur/Membre du Conseil chez
NAUTILUS BIOTECHNOLOGY, INC.
Fortune : 494 055 $ au 31/05/2026
Profil
Melissa B. Epperly currently works at Roivant Sciences Ltd., as Independent Director from 2022, Nautilus Subsidiary, Inc., as Director, Nautilus Biotechnology, Inc., as Independent Director from 2021, and The Andalusia Foundation, as Trustee.
Ms. Epperly also formerly worked at Anchorage Capital Group LLC, as Director from 2012 to 2015, Kinnate Biopharma, Inc., as Independent Director from 2020 to 2024, Goldman Sachs International, as Research Analyst, Goldman Sachs & Co. LLC, as Analyst from 2010 to 2012, Akamis Bio Ltd., as Chief Financial Officer from 2018 to 2019, R-Pharm US LLC, as CFO & Head-Business Development from 2015 to 2018, and Zentalis Pharmaceuticals, Inc., as Treasurer, Chief Financial & Accounting Officer from 2019 to 2024.
Ms. Epperly received her undergraduate degree from the University of Virginia and Masters Business Admin degree from Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/04/2026 | 16 474 ( 0 % ) | 494 055 $ | 31/05/2026 | |
| 20/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Melissa Epperly
| Sociétés | Poste | Début |
|---|---|---|
| NAUTILUS BIOTECHNOLOGY, INC. | Directeur/Membre du Conseil | 09/06/2021 |
| ROIVANT SCIENCES LTD. | Directeur/Membre du Conseil | 29/06/2022 |
Nautilus Subsidiary, Inc.
 Nautilus Subsidiary, Inc. Information Technology ServicesTechnology Services Provides single-molecule protein analysis software services | Directeur/Membre du Conseil | - |
The Andalusia Foundation
 The Andalusia Foundation Miscellaneous Commercial ServicesCommercial Services The Andalusia Foundation is a company that operates in the Restaurants industry. It was founded in 1795 by John Craig. The Andalusia Foundation is based in Andalusia, PA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Melissa Epperly
| Sociétés | Poste | Fin |
|---|---|---|
| ZENTALIS PHARMACEUTICALS, INC. | Directeur Financier/CFO | 05/04/2024 |
| KINNATE BIOPHARMA INC. | Directeur/Membre du Conseil | 03/04/2024 |
Akamis Bio Ltd.
 Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Directeur Financier/CFO | 01/08/2019 |
R-Pharm US LLC
 R-Pharm US LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of medicines to treat cancer | Directeur Financier/CFO | 01/06/2018 |
Anchorage Capital Group LLC
 Anchorage Capital Group LLC Investment ManagersFinance Anchorage Capital Group manages private investment funds across the credit, special situations and illiquid investment markets of North America and Europe using an active long and short basis, with particular focus on defaulted and leveraged issuers. | Directeur/Membre du Conseil | 01/09/2015 |
Formation de Melissa Epperly
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Goldman Sachs International
 Goldman Sachs International Financial ConglomeratesFinance Provides financial services | Finance |
Anchorage Capital Group LLC
Anchorage Capital Group LLC Investment ManagersFinance Anchorage Capital Group manages private investment funds across the credit, special situations and illiquid investment markets of North America and Europe using an active long and short basis, with particular focus on defaulted and leveraged issuers. | Finance |
Roivant Sciences Ltd.
 Roivant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company through its subsidiaries develops restorative therapies for autoimmune diseases | Health Technology |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Goldman Sachs & Co. LLC
 Goldman Sachs & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Akamis Bio Ltd.
Akamis Bio Ltd. BiotechnologyHealth Technology Operates as a clinical-stage oncology company that engages in development of tumor gene therapies | Health Technology |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of medicines to treat cancer | Health Technology |
Zentalis Pharmaceuticals, Inc.
 Zentalis Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops clinical therapeutics for targeting fundamental cancer pathways | Health Technology |
Kinnate Biopharma, Inc.
 Kinnate Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage precision oncology company | Health Technology |
Nautilus Subsidiary, Inc.
Nautilus Subsidiary, Inc. Information Technology ServicesTechnology Services Provides single-molecule protein analysis software services | Technology Services |
Nautilus Biotechnology, Inc.
 Nautilus Biotechnology, Inc. BiotechnologyHealth Technology Develops proteomics platform for analyzing and quantifying the human proteome | Health Technology |
The Andalusia Foundation
The Andalusia Foundation Miscellaneous Commercial ServicesCommercial Services The Andalusia Foundation is a company that operates in the Restaurants industry. It was founded in 1795 by John Craig. The Andalusia Foundation is based in Andalusia, PA. | Commercial Services |
